A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer’s and gout.
University of Queensland researchers have uncovered how an inflammation process automatically switches off in healthy cells, and are now investigating ways to stop it manually when it goes awry.
“Now that we understand how this pathway naturally turns off in health, we can investigate why it doesn’t turn off in disease — so it’s very exciting,” Dr Schroder said.
Her work at IMB’s Centre for Inflammation and Disease Research focuses on inflammasomes, which are machine-like protein complexes at the heart of inflammation and disease.
“These complexes form when an infection, injury or other disturbance is detected by the immune system, and they send messages to immune cells to tell them to respond,” Dr Schroder said.
“If the disturbance can’t be cleared, such as in the case of amyloid plaques in Alzheimer’s, these molecular machines continue to fire, resulting in neurodegenerative damage from the sustained inflammation.”
Dr Schroder’s team, led by Dr Dave Boucher, discovered that inflammasomes normally work with an in-built timer switch, to ensure they only fire for a specific length of time once triggered.
“The inflammasome initiates the inflammation process by activating a protein that functions like a pair of scissors, and cuts itself and other proteins,” Dr Schroder said.
“What we’ve found is that after a period of time this protein cuts itself a second time to turn off the pathway, so if we can tweak this system we may be able to turn it off manually in disease.”
Dr Schroder’s laboratory has begun studying the inflammasome in fatty liver disease, a rapidly growing health issue due to the increasing global incidence of obesity and diabetes.
“In some patients with this condition the liver becomes increasingly fatty and inflamed, and this can lead to cirrhosis – which can require liver transplantation – or even liver cancer.”
Compounds to block inflammasome have been developed by IMB researchers including Dr Schroder, and are being commercialised by start-up drug development company Inflazome Ltd.
The research, published in the Journal of Experimental Medicine (DOI: 10.1084/jem.20172222), was supported by the Australian Research Council, and involved laboratories at IMB and the UQ School of Chemistry and Molecular Biosciences.
Imaging for the project was performed in the IMB Cancer Biology Imaging Facility, funded by the Australian Cancer Research Foundation.
Additional video: inflammasome animation on YouTube.
The Latest on: Uncontrolled inflammation
via Google News
The Latest on: Uncontrolled inflammation
- Inflammation triggered by obesity may cause brain damageon November 30, 2019 at 8:30 am
the inflammation from obesity may lead to brain damage starting at ages as young as 12. The damage was identified in the orbitofrontal gyrus and corpus callosum, areas of the brain that have to do ...
- Could inflammation be behind postpartum depression?on November 29, 2019 at 8:44 pm
Inflammation is a normal part of the body's immune response ... Depression during and after pregnancy. U.S. Centers for Disease Control and Prevention.
- New app empowers patients living with inflammatory bowel disease to manage health and wellnesson November 28, 2019 at 4:22 pm
TORONTO, Nov. 28, 2019 (GLOBE NEWSWIRE) -- As part of its commitment to improve quality of life for the more than quarter-million Canadians living with inflammatory bowel diseases, Crohn’s and Colitis ...
- Dermatologists share their tips for reducing red skin and inflammationon November 28, 2019 at 5:17 am
People with uncontrolled eczema tend to get secondary infection,” said Dr. Howard Sobel ... Seborrheic dermatitis is caused by an overgrowth of yeast on the skin that leads to redness, inflammation ...
- Obesity 'triggers inflammation that damages the brain’on November 28, 2019 at 3:44 am
And in the US, one in five (20.6%) of 12-to-19 year olds are obese, data from the Centers for Disease Control and Prevention reveals. Obesity is known to cause inflammation, which has been linked to ...
- Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibitionon November 28, 2019 at 2:20 am
Protocol 3: To test uremia-driven inflammatory stimuli, A7r5 cells were exposed to either control serum (a pool from rats with normal renal function fed a normal P diet; DMEM + 10% control serum), or ...
- Mechanism and therapeutic effect of umbilical cord mesenchymal stem cells in inflammatory bowel diseaseon November 27, 2019 at 2:07 am
Inflammatory bowel disease (IBD) is a persistent and chronic disease that is characterized ... In the chronic IBD study, the survival rates of the normal control, model, mouse UCMSC (mUCMSC) and human ...
- ChemoCentryx Stock More Than Triples On Late-Stage Readout For Rare Inflammatory Disease Drugon November 26, 2019 at 6:20 am
BVAS remission at week 26 was achieved in 72.3% of avacopan-treated subjects versus 70.1% for the SOC control group, and sustained remission at 52 weeks was observed in 65.7% of avacopan-treated ...
- Essential Science: Linking inflammation with mental sluggishnesson November 24, 2019 at 7:14 pm
The level of inflammation was assessed via a blood test. Attentiveness was assessed by considering: "Alerting" which involves reaching and maintaining an alert state. "Orienting" which involves ...
via Bing News